Category: RSV

Respiratory Virus Vaccine Recommendations

Posted on by

The American Academy of Family Practioners (AAFP), the American Academy of Pediatrics (AAP), the American Medical Association (AMA), the Vaccine Integrity Project (VIP), the American College of Obstetrics and Gynecology (ACOG), and the Infectious Disease Society of America (IDSA) have put together Respiratory Virus Immunization Recommendations. https://www.ama-assn.org/system/files/respiratory-virus-immunization-recommendations.pdf Have a gander, and tell your friends!

Vaccine Integrity Project and American Medical Association Announces Independent 2026-2027 Respiratory Season Vaccine Evidence Review

Posted on by

Tuesday, September 2. The Vaccine Integrity Project, in collaboration with the American Medical Association (AMA), today announced its independent, 2026-27 respiratory season vaccine evidence review, assessing the safety and effectiveness of respiratory virus season immunizations. The latest, high-quality scientific evidence found that immunizations against influenza, COVID-19 and respiratory syncytial virus (RSV) continue to provide meaningful protection against severe illness, hospitalization and death. The Vaccine Integrity Project undertook the review to both analyze effectiveness but also to look for any safety signals that may have emerged in the data gathered since its last evidence review in summer 2025. Reassuringly, researchers found Read More …

RSV Guidance Updated

Posted on by

The Centers for Disease Control and Prevention (CDC) updated its RSV vaccine guidance for seniors for this upcoming respiratory viral season, saying the new recommendations are meant to simplify decision-making for patients and clinicians. The new guidance recommends that everyone over the age of 75 get the RSV vaccine, as well as anyone aged 60 to 74 who is “at increased risk of severe RSV.” Read more

Posted in RSV

More RSV Shots on the Way

Posted on by

December 14, 2023 Politico.com The White House announced Thursday it struck a deal with drug manufacturers to make available 230,000 more doses of the respiratory syncytial virus shot for infants by January, amid a widespread shortage that’s had parents and pediatricians scrambling to find shots. The move comes after weeks of pressure from top Biden administration officials, who were speaking almost daily with the drug companies in an effort to ramp up supply, three people familiar with the matter told POLITICO. Read more The White House On Wednesday, senior Biden-Harris Administration officials met again with manufacturers of RSV immunizations including Sanofi and AstraZeneca Read More …

Posted in RSV